Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov-Dec;88(6):937-44.
doi: 10.1590/abd1806-4841.20132018.

Treatment of superficial mycoses: review. Part II

Maria Fernanda Reis Gavazzoni Dias  1 , Fred Bernardes-Filho  2 , Maria Victória Pinto Quaresma-Santos  2 , Adriana Gutstein da Fonseca Amorim  3 , Regina Casz Schechtman  4 , David Rubem Azulay  5
Affiliations
Review

Treatment of superficial mycoses: review. Part II

Maria Fernanda Reis Gavazzoni Dias et al. An Bras Dermatol. 2013 Nov-Dec.

Abstract
in English, Portuguese

Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets.

As infecções fúngicas superficiais dos cabelos, pele e unhas representam uma causa importante de morbidade no mundo. O tratamento nem sempre é simples, havendo dificuldade na escolha dos esquemas terapêuticos disponíveis na literatura, assim como suas possíveis interações medicamentosas e efeitos colaterais. A segunda parte do trabalho aborda os principais esquemas terapêuticos das micoses superficiais - ceratofitoses, dermatofitoses, candidíase -, possibilitando a consulta prática das drogas tópicas e sistêmicas mais utilizadas, sua dosagem e tempo de utilização. Novas possibilidades terapêuticas antifúngicas também são ressaltadas, assim como as apresentações disponíveis no mercado brasileiro e mundial.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

References

    1. Verma S, Heffernan MP. Superficial fungal infection: dermatophytosis, tinea nigra, piedra. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2008. pp. 1807–1821.
    1. Hay RJ, Ashbee HR. Superficial mycoses. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th ed. New Jersey: Wiley Blackwell; 2010. pp. 36.5–36.68.
    1. Sobera JO, Elewski BE. Fungal diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. New York: Mosby Elsevier; 2008. pp. 1135–1149.
    1. Croxtall JD, Plosker GL. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynecology. Drugs. 2009;69:339–359. - PubMed
    1. Lacaz CS, Porto E, Martins JEC, Heins-Vaccari EM, Melo NT. Tratado de Micologia Médica (Medical Mycology Treaty).Lacaz. 9. ed. São Paulo: Sarvier; 2002. pp. 252–340.

Substances

LinkOut - more resources